Tag: Inspire Medical

MINNEAPOLIS – Inspire Medical, the maker of an FDA-approved neurostimulation device to treat obstructive sleep apnea, expects revenue of $137.5 million to $137.9 million for the fourth quarter of 2022, about a 76% increase year over year. It expects revenue for the full year to be $407.5 million to $407.9 million, about a 75% increase compared to 2021. “We are very pleased with our strong preliminary revenue performance in the fourth quarter primarily driven by higher utilization at existing...

MAPLE GROVE, Minn. - Inspire Medical Systems has accumulated $37.5 million in venture funding as it prepares to increase sales of its pacemaker-sized, implantable device used to treat sleep apnea. New York-based investor Amazak Health led the round of funding, CEO Tim Herbert told the Minneapolis/St. Paul Business Journal. Previous investors, including OrbiMed Advisors and Medtronic, also participated in the round. The company received $12.5 million a few weeks ago and will get the rest next year....